Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Inamoto

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|February 15, 2017
Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantationY Tanaka, S Kurosawa, K Tajima, et al.
Bone Marrow Transplantation|January 12, 2016
Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantationY Tanaka, S Kurosawa, K Tajima, et al.
Bone Marrow Transplantation|April 19, 2011
Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCTN Imahashi, Y Inamoto, M Ito, et al.
Bone Marrow Transplantation|March 21, 2017
Clinical impact of hyperglycemia on days 0-7 after allogeneic stem cell transplantationA Kawajiri, S Fuji, Y Tanaka, et al.
Bone Marrow Transplantation|November 9, 2010
Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan Marrow Donor ProgramY Inamoto, K Miyamura, S Okamoto, et al.
Bone Marrow Transplantation|January 29, 2013
Measurement of oral chronic GVHD: results from the Chronic GVHD ConsortiumN Treister, X Chai, B Kurland, et al.
Bone Marrow Transplantation|January 28, 2014
Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHDY Inamoto, M Jagasia, W A Wood, et al.
Bone Marrow Transplantation|November 23, 2006
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantationY Inamoto, T Nishida, R Suzuki, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 19, 2016
Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung TransplantationX Liu, Z Yue, J Yu, et al.
Bone Marrow Transplantation|December 13, 2016
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetilS Terakura, A Wake, Y Inamoto, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|February 15, 2017
Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantationY Tanaka, S Kurosawa, K Tajima, et al.
Bone Marrow Transplantation|January 12, 2016
Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantationY Tanaka, S Kurosawa, K Tajima, et al.
Bone Marrow Transplantation|April 19, 2011
Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCTN Imahashi, Y Inamoto, M Ito, et al.
Bone Marrow Transplantation|March 21, 2017
Clinical impact of hyperglycemia on days 0-7 after allogeneic stem cell transplantationA Kawajiri, S Fuji, Y Tanaka, et al.
Bone Marrow Transplantation|November 9, 2010
Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan Marrow Donor ProgramY Inamoto, K Miyamura, S Okamoto, et al.
Bone Marrow Transplantation|January 29, 2013
Measurement of oral chronic GVHD: results from the Chronic GVHD ConsortiumN Treister, X Chai, B Kurland, et al.
Bone Marrow Transplantation|January 28, 2014
Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHDY Inamoto, M Jagasia, W A Wood, et al.
Bone Marrow Transplantation|November 23, 2006
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantationY Inamoto, T Nishida, R Suzuki, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 19, 2016
Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung TransplantationX Liu, Z Yue, J Yu, et al.
Bone Marrow Transplantation|December 13, 2016
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetilS Terakura, A Wake, Y Inamoto, et al.
Pageof 8